ABSTRACT
INTRODUCTION
Over the last decade, it has become evident that a proportion of third-trimester fetuses with estimated fetal weight (EFW) < 10 th centile and normal flow in the umbilical artery are in fact growth-restricted rather than merely small-for-gestational age (SGA) 1 . Thus, the concept of late fetal growth restriction (FGR) was introduced to describe fetuses with placental failure that is not severe enough to result in early profound FGR with abnormal umbilical artery flow, but it is severe enough to be associated with higher risk of perinatal and long-term complications 1, 2 . As these fetuses are exposed to mild hypoxia, their degree of cardiovascular adaptation is limited, which, in combination with the increased oxygen needs during the third trimester, decreases their tolerance to acute hypoxic episodes and makes their prenatal course rather unpredictable 3 .
Timely recognition could improve the outcome of these fetuses by altering their follow-up and timing of delivery 3 . However, late FGR is difficult to diagnose 3 . So far, there are only limited data regarding screening for, and detection of, fetuses at risk for developing late FGR [4] [5] [6] [7] [8] .
The aim of this study was to develop a first-trimester or combined first-and second-trimester screening algorithm for the prediction of SGA and late FGR.
METHODS
The study is reported according to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement and checklist (https://www .strobe-statement.org).
This was a retrospective study of women with singleton pregnancy, who underwent first-, second-and third-trimester ultrasound examinations as part of their routine antenatal care, and the outcome of their pregnancy was recorded.
The study was a collaboration between two private (Athens and Thessaloniki, Greece) and one public (Third Department of Obstetrics and Gynecology, University of Athens, Greece) prenatal care centers. Data of women attending for their routine first-, second-and third-trimester fetal ultrasound examinations between January 2014 and December 2016 were entered prospectively in a fetal database (Astraia Software GmbH, Munich, Germany), and data on pregnancy outcome were collected within 4 months after the expected delivery date.
Women with pregnancy progressing beyond 32 weeks, who had all three routine ultrasound examinations at our institutions and for whom the outcome of pregnancy could be collected, were eligible for inclusion. Women with termination of pregnancy, intrauterine death or stillbirth before 32 weeks were excluded from the analysis because, by definition, SGA and late FGR require an ongoing pregnancy at 32 weeks.
All women gave informed consent for their anonymized data to be potentially used for research. As per standard policy for observational database studies not involving any intervention or modification of the management of the participants, no institutional review was required.
Variables
Appropriate-for-gestational-age fetuses were defined as those with EFW ≥ 10 th centile at ≥ 32 weeks.
Late FGR was defined 3,4,9 as fetuses which, at any point at or after 32 + 0 weeks, had normal umbilical artery waveform (pulsatility index (PI) < 95 th centile for gestational age (GA)), absence of congenital anomalies and had either (i) EFW 10 or birth weight (BW) 11 < 3 rd centile, or (ii) EFW < 10 th centile and either mean uterine artery PI (UtA-PI) > 95 th centile 12 or cerebroplacental ratio < 5 th centile 13 . This is a modification of the recently published consensus definition of FGR 14 , in that (i) the criterion of crossing centiles was not used, as serial scans are not usually performed routinely in the presence of normal growth, and (ii) we also included the postnatal criterion of BW < 3 rd centile, as prenatal detection of small fetuses can commonly be suboptimal.
SGA was defined as BW < 10 th centile 11 , regardless of prenatal parameters. As such, SGA was a postnatal diagnosis and was not mutually exclusive with late FGR.
Data sources and measurement
All prenatal ultrasound examinations were performed by Fetal Medicine Foundation (FMF) certified examiners. Crown-rump length (CRL) was measured in a neutral fetal position and the formula of Robinson and Fleming 15 , as referenced by Loughna et al. 16 , was used to calculate GA; all subsequent scans were dated according to CRL if, at this first visit, the discrepancy between CRL-based and last menstrual period-based GA was ≥ 5 days 17 . Maternal serum free beta-human chorionic gonadotropin (hCG) and pregnancy-associated plasma protein-A (PAPP-A) were measured using either a Brahms Kryptor (Thermo Fisher Scientific, Hennigsdorf, Germany) or a Roche Elecsys (Roche Diagnostics Ltd., Switzerland) analyzer. The measured concentrations of the two hormones were converted to multiples of the median (MoM) corrected for fetal CRL, maternal weight, smoking status, racial origin, parity and method of conception according to the FMF software, as described before 18 . First-trimester (transvaginal) and second-or third-trimester (transabdominal) assessment of the UtA Doppler was performed as described previously 19, 20 , and the mean PI was calculated. The middle cerebral artery was examined in an axial view of the fetal head, at a point within the inner one-third of its course to the circle of Willis in fetuses ≥ 32 weeks. A free loop of the umbilical cord was selected for the assessment of umbilical artery flow, and care was taken to ensure an insonation angle < 30
• for all Doppler measurements. The methodology for measuring fetal biometric parameters has been described elsewhere 21 . EFW was calculated according to the formula of Hadlock et al. 22 as it has been shown to have consistently high accuracy for most gestational periods and fetal sizes [23] [24] [25] [26] . Then, the absolute values of EFW were converted into centiles using the formula described by Yudkin et al. 10 , which was the default method in the Astraia fetal database. Ultrasound examinations were performed using a 2.0-8.0-MHz convex transabdominal volume probe or a 4.0-9.0-MHz endocavitary volume probe, connected to a Voluson E6 Expert or E8 Expert scanner (GE Healthcare Ultrasound, Milwaukee, WI, USA). Information about pregnancy outcome was collected from the hospital records, or through communication with the mothers or their obstetricians.
Quantitative variables
Potential predictors of late FGR (overall) were tested in two models: one using maternal and first-trimester parameters, and a second using maternal, firstand second-trimester parameters. We applied these models for the prediction of overall late FGR, prenatally detected FGR and SGA.
Potential predictors included maternal age, conception method (spontaneous vs assisted), smoking during pregnancy (yes/no), maternal weight, maternal height, mean UtA-PI in the first and second trimester (expressed as standardized residuals (Z-scores)), first-trimester free beta-hCG (MoM), first-trimester PAPP-A (MoM), second-trimester head circumference/abdominal circumference (HC/AC) ratio (expressed as Z-score) and second-trimester EFW (expressed as Z-score) 27 . The equation of Gomez et al. 12 was used to convert first-and second-trimester mean UtA-PI raw values to Z-scores. We used an equation published previously by our group for the conversion of estimated fetal growth to Z-scores 27 , and we calculated the equation for the HC/AC ratio using data from another published research dataset of our centers 21 , using the methodology described by Royston and Wright 28 . The HC/AC ratio was best described by a quadratic equation: log 10 HC/AC = 0.041752 + 0.003356 × GA weeks -0.000113 × GA 
Statistical analysis
Descriptive statistics (mean ± SD, median (range) or proportions with 95% CI) were calculated as appropriate for each group. Comparisons were made using ANOVA/Student's t-test or Mann-Whitney U-test for continuous variables, depending on their distribution, while chi-square test was performed for categorical variables. Logistic regression (backward, using likelihood ratios) was performed separately for SGA and late FGR, using the predictors described above. For each of the two outcomes (SGA and late FGR) we tested two models, i.e. one using only maternal and first-trimester factors, and one combining maternal, first-trimester factors and second-trimester factors. The predicted probabilities from each regression model were saved as separate variables and their accuracy was assessed using receiver-operating characteristics (ROC) curve analysis. IBM SPSS 22.0 (IBM Corp, Armonk, NY, USA) and open source software R 2.15.1 (The R Foundation for Statistical Computing, package pROC version 1.7.2) were used for statistical analysis and graph construction.
RESULTS
Following the initial database search, 4335 women fulfilled the eligibility criteria. Of these, 815 (18.8%) cases had missing data for at least one of the recorded factors, leaving 3520 women for analysis. Cases with missing data differed from those with full data available in: maternal height (taller), weight (lighter), PAPP-A (lower), second-trimester UtA-PI (lower) and second-trimester EFW Z-scores (lower) ( Table S1 ).
A total of 292 (8.3%) infants were SGA and 109 (3.1%) infants were defined as late FGR. Descriptive data for late FGR and non-FGR groups are reported in Table 1 . Maternal age and weight were similar between the two groups, but women were taller in the non-FGR group. There were significant differences between the two groups in the rates of smoking and assisted conception, in first-trimester PAPP-A level, first-and second-trimester mean UtA-PI Z-scores, second-trimester EFW Z-scores and second-trimester log 10 (HC/AC) ratio Z-scores (Figure 1) . Mean GA at birth and mean BW centile also differed between the two groups. The rate of neonatal intensive care unit (NICU) admission was significantly higher in the late FGR group (18.3%) compared with the non-FGR group (2.1%).
Of the 109 late FGR infants, 56 met prenatal criteria for FGR. Comparative data for antenatally diagnosed vs undiagnosed late FGR cases are shown in Table S2 . Compared to fetuses with BW < 3 rd centile that were not diagnosed prenatally with late FGR, antenatally detected late FGR was associated with higher resistance in the UtA in both first and second trimesters, lower EFW and BW, lower GA at birth and a higher rate of NICU admission. A model combining maternal factors and first-and second-trimester parameters (conception method, smoking status, PAPP-A MoM, second-trimester EFW Z-score, second-trimester HC/AC Z-score and second-trimester mean UtA-PI Z-score) improved significantly the prediction of the first-trimester model, for overall FGR (P < 0.001), antenatally detected FGR (P < 0.001) and SGA (P < 0.001). For a 10% FPR, this combined first-and second-trimester model predicted 78.6% of antenatally diagnosed late FGR, 59.6% of the overall late FGR cases and 41.8% of SGA infants ( Figure 2 , Table 2 ). Pairwise comparisons of AUC showed that prediction of prenatally detected FGR (AUC, 0.901 (95% CI, 0.856-0.947); P < 0.001) and of overall FGR (AUC, 0.855 (95% CI, 0.819-0.891); P = 0.003) was significantly better than that of SGA (AUC, 0.784 (95% CI, 0.755-0.812)). AUC, of prenatally detected FGR did not differ significantly from that of overall FGR (P = 0.136) (Figure 2 ).
The predictive performance of the combined model for different FPRs is shown in Table 2 . Table S3 shows the parameters included in the first-and combined first-and second-trimester models.
DISCUSSION

Key results
The overall rate of late FGR was 3.1% in our cohort; approximately half of these cases were classified prenatally as such. Using a combination of maternal and first-and second-trimester factors, the detection rate for a 10% FPR was good for late FGR (78.6%) detected antenatally, acceptable for overall late FGR (59.6%) and poor for SGA (41.8%).
Strengths and limitations
Screening for late FGR is a novel concept, since late FGR itself has only recently been acknowledged as a separate diagnosis. Although there is still some heterogeneity in defining late FGR 3,14 , the criteria described by Figueras and Gratacós et al. 3, 4, 9 identified the most clinically relevant high-risk group in our cohort, as shown by the significant difference in NICU admission rate between late FGR (18.3%) and non-FGR (2.1%) cases. Our screening model is simple and affordable, as it included the standard tests used in screening for chromosomal abnormalities, with the addition of only the measurement of UtA-PI in the first trimester.
The main limitation of this study is its retrospective design. As a result, 18.8% of the eligible cases had missing data for one or more of the potential predictors and were excluded from the analysis. We opted for this policy rather than completing missing data by imputation, as this might have affected the validity of the models. Although some of the baseline characteristics differed between cases with full and those with missing data, they did so in a non-systematic way. For example, some of the risk factors for late FGR (e.g. lower second-trimester EFW, lower PAPP-A levels) were more common in the group with missing data, whereas other risk factors (e.g. higher second-trimester UtA resistance) were more common in the full-data group. This inconsistent pattern of differences and the retrospective, non-interventional design of this study make them unlikely to have resulted in systematic bias. Another limitation is that we used the commercially available centile calculation 10 for defining EFW centile at ≥ 24 weeks at our initial ultrasound examination, whereas we used our own published formula 27 to calculate EFW Z-scores at the second-trimester ultrasound examination. We used the Yudkin et al. formula 10 for defining fetal growth at ≥ 32 weeks because this was the only formula available in our software when the examinations were performed, and subsequent clinical management was based on this. The formula of Yudkin et al. 10 refers to BW rather than EFW, and this may explain why the rate of fetuses with EFW < 10 th centile and those with prenatally detected late FGR were lower than expected (5.5% and 1.5%, respectively). Alternatively, our population may have been mostly low-risk, apparently due to the inclusion of private patients. Finally, approximately 99% of the women were of Caucasian ethnic origin, preventing us from controlling for racial differences.
Interpretation
We found that a simple model combining maternal factors and first-and second-trimester parameters can predict 60% of the fetuses that will develop late growth restriction and 80% of the cases that will be prenatally classified as late FGR, for a 10% FPR. A recent prospective study reported that a combination of maternal factors (chronic hypertension, autoimmune disease, previous FGR, smoking status, nulliparity, mean arterial pressure) and first-trimester pre-eclampsia markers (UtA-PI, placental growth factor and soluble fms-like tyrosine kinase-1) could predict 66% of late FGR cases, for a FPR of 10% 4 . This is clearly superior to the 37% we achieved with first-trimester screening, and can be an advantage if first-trimester prevention strategies are to be implemented. However, that model was constructed under a nested case-control design, which is more prone to statistical over-fitting and over-optimistic performance than is a full prospective cohort study. On the other hand, our model was quite simple and cheaper, including only UtA Doppler measurement in addition to the default tests for first-trimester screening for chromosomal abnormalities, so this could prove a more feasible policy for low-resource settings.
Contingent screening models appear to be more sensitive than is first-trimester screening alone. Our detection rate improved from 37% to 60%, for a 10% FPR, as also reported previously 5 . A rationale for detecting fetuses at high risk for late FGR would be to offer them closer monitoring in the third trimester, especially as these fetuses are at a high risk for NICU admission. This may prove relevant for systems which do not normally offer a third-trimester ultrasound examination to all women. A recent validated, contingent three-step (first-, second-and third-trimester) model concluded that the screen-positive rate should be as high as 50% to match the universal third-trimester scan 5 . Our two-step (first-and second-trimester) model appears to have higher specificity, detecting as many as 60% of late FGR fetuses for a FPR of 10%, and 83% for a 30% FPR.
The ultimate aim of screening is to identify patients for whom timely intervention may alter the natural progression of the disease. Although late FGR has not been specifically addressed, pooled data from randomized trials show that early administration of low-dose aspirin in women at high risk for pre-eclampsia can reduce the risk for fetal/neonatal weight < 10 th centile (pooled relative risk (RR) 0.76; 95% CI, 0.65-0.89) [29] [30] [31] [32] [33] [34] [35] [36] and for fetal/neonatal weight < 3 rd centile (pooled RR 0.7; 95% CI, 0.49-0.99) 29, 30, 37, 38 . Therefore, contingent screening enhances recognition of late FGR fetuses, but effective first-trimester detection would be needed for their potential prevention.
Generalizability
The two most significant challenges with respect to late FGR are the heterogeneity in its definition 3, 9, 14 and suboptimal prenatal recognition. Prenatal management is based unavoidably on fetal measurements, and EFW is therefore used as a proxy for BW; however, this approximation is not always accurate. The performance of our model was considerably better in the prediction of those late FGR cases that were prenatally identified based on EFW and Doppler criteria 3, 9 (79% prediction at a 10% FPR), compared with the performance achieved for the prediction of overall late FGR (60% prediction at a 10% FPR). Cases that were classified antenatally as late FGR had higher resistance in the uterine arteries, lower GA at birth and greater rate of NICU admission than those identified postnatally. Therefore, it is reasonable to conclude that prenatally identified cases belonged to the more severe end of the spectrum, and our regression model preferentially predicted these more severe cases. The differences in the UtA between prenatally and postnatally identified cases may be reflective of their different degree of placental dysfunction 39 . This being a retrospective study, the generalizability of our results needs to be validated prospectively.
Conclusion
While a combination of first-and second-trimester maternal and fetal characteristics detected 60% of the fetuses that developed late FGR and 80% of those identified prenatally as late FGR, for a 10% FPR, the prediction of SGA was poor.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article: Table S1 Baseline characteristics of cases with full data on predictors (included in main analysis) and cases with missing data for one or more predictors (excluded from main analysis) 
